文献速递心血管泌尿生殖技术与安全PET

美国联邦医疗保险受益者中伴与不伴慢性肾脏病者心脏负荷试验的比较使用情况及时间趋势

Comparative Utilization and Temporal Trends in Cardiac Stress Testing in U.S. Medicare Beneficiaries With and Without Chronic Kidney Disease.
PubMed 文献 · JACC Cardiovasc Imaging · 2018-06-13

该研究基于2008至2012年20%联邦医疗保险样本,每年约450万受益者,分析66岁以上患者首次心脏负荷试验的使用趋势与类型。结果显示负荷试验率从2008至2012年总体下降,非慢性肾脏病患者从11.5降至9.4每100患者年,慢性肾脏病患者从16.8降至13.4每100患者年,且慢性肾脏病患者各期校正后负荷试验可能性更高,其中5期透析患者发生率比1.15(P<0.0001)。

要点

  • 2008至2012年联邦医疗保险66岁以上患者心脏负荷试验率总体下降,但慢性肾脏病患者始终高于非慢性肾脏病患者。
  • 非慢性肾脏病患者78%至80%的负荷试验使用核素显像,慢性肾脏病患者为87%至88%。
  • 以非慢性肾脏病为参照,5期透析患者校正后负荷试验发生率比为1.15(P<0.0001),3期为1.05(P<0.0001)。

核心结论

  • 2008至2012年联邦医疗保险66岁以上受益者心脏负荷试验总体率下降,但慢性肾脏病患者始终高于非慢性肾脏病患者,数据反驳了慢性肾脏病患者负荷试验使用不足的说法。

研究设计与样本

  • 使用2008至2012年20%联邦医疗保险样本,每年构建约450万受益者的年度队列;纳入66岁以上、首次心脏负荷试验、无既往冠状动脉血运重建史且60天内无急性冠脉综合征的受益者;采用Poisson回归模型按慢性肾脏病分期估计2012年负荷试验可能性,并校正人口学特征与合并症。

诊断标准与关键数值

  • 以非慢性肾脏病为参照,校正后负荷试验发生率比:1至2期1.01(P无统计学意义),3期1.05(P<0.0001),4期1.01(P无统计学意义),5期非透析1.04(P无统计学意义),5期透析1.15(P<0.0001)。
  • 2008至2012年负荷试验率:非慢性肾脏病患者从11.5降至9.4每100患者年,慢性肾脏病患者从16.8降至13.4每100患者年。

局限性

  • 原文指出筛查算法对移植候选者的影响未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The authors aimed to analyze temporal trends in cardiac stress testing in U.S. Medicare beneficiaries from 2008 to 2012, types of stress testing, and comparative utilization related to the presence and severity of chronic kidney disease (CKD).

BACKGROUND: A long-held perception depicts patients with CKD as being treated less intensively for cardiovascular disease than nonrenal patients. We wondered whether use of diagnostic testing for ischemic heart disease is affected by the presence of CKD.

METHODS: Using the 20% Medicare sample, we assembled yearly cohorts of Medicare beneficiaries (∼4,500,000 per year) from 2008 to 2012. Beneficiaries 66 years or older undergoing a first cardiac stress test, with no previous history of coronary revascularization and no acute coronary syndrome within 60 days, were identified, as was the type of stress test. We analyzed temporal trends and compared testing rates related to CKD stage versus no CKD. A Poisson regression model estimated the likelihood of stress testing in 2012 by CKD stage, adjusted for demographic characteristics and comorbid conditions.

RESULTS: Approximately 480,000 older patients (∼29,000 with CKD) underwent stress tests in 2008, progressively declining to ∼400,000 in 2012 (∼38,000 with CKD). In 2008 to 2012, 78% to 80% of all stress testing in non-CKD patients used nuclear imaging, as did 87% to 88% in CKD patients. Rates of stress testing declined progressively for non-CKD and CKD patients in 2008 to 2012: 11.5 to 9.4 per 100 patient-years and 16.8 to 13.4 per 100 patient-years, respectively. The adjusted Poisson model, with non-CKD as the reference, showed an increasing likelihood of stress testing with worsening CKD: incidence rate ratio 1.01 for stages 1 to 2 (p = NS), 1.05 for stage 3 (p < 0.0001), 1.01 for stage 4 (p = NS), 1.04 for stage 5 nondialysis (p = NS), and 1.15 for stage 5 dialysis (p < 0.0001).

CONCLUSIONS: Overall rates of cardiac stress testing (over three-fourths using nuclear imaging) declined in 2008 to 2012 among Medicare beneficiaries 66 years or older but were consistently higher for CKD than for non-CKD patients. The effect of screening algorithms for transplant candidates was unknown. Our data refute underutilization of cardiac stress testing in CKD patients.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Herzog CA, Natwick T, Li S, et al. Comparative Utilization and Temporal Trends in Cardiac Stress Testing in U.S. Medicare Beneficiaries With and Without Chronic Kidney Disease. JACC Cardiovasc Imaging. 2018. PMID: 29909107. doi:10.1016/j.jcmg.2018.04.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。